Australian bat lyssavirus: Implications for public health

Medical Journal of Australia

Volumn 201, Issue 11, 2014, Pages 647-649

  Francis, Joshua R ^a   McCall, Bradley J ^b   Hutchinson, Penny ^c   Powell, Jodie ^d   Vaska, Vikram L ^e   Nourse, Clare ^d  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b Metro South Mental Health   (Australia)

^c Darling Downs Public Health Unit   (Australia)

^d MATER HOSPITAL   (Australia)

^e Mater Pathology Services   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ARTICLE; AUSTRALIA; AWARENESS; BAT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; ENCEPHALITIC RABIES; HUMAN; LYSSAVIRUS; LYSSAVIRUS GENOTYPE 7; MEGACHIROPTERA; NEUROIMAGING; POST EXPOSURE PROPHYLAXIS; PUBLIC HEALTH; RABIES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SPECIES ENDEMICITY; VIRUS TRANSMISSION; ANIMAL; BITES AND STINGS; DISEASE CARRIER; RHABDOVIRIDAE INFECTIONS; TRANSMISSION; VIROLOGY;

ANIMALS; AUSTRALIA; BITES AND STINGS; CHIROPTERA; DISEASE VECTORS; HUMANS; LYSSAVIRUS; PUBLIC HEALTH; RHABDOVIRIDAE INFECTIONS;

EID: 84924760364     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.00261     Document Type: Article

References (25)

1. Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet 2004; 363: 959-969.
2. Guyatt KJ, Twin J, Davis P, et al. A molecular epidemiological study of Australian bat lyssavirus. J Gen Virol 2003; 84 (Pt 2): 485-496.
3. Samaratunga H, Searle JW, Hudson N. Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection. Neuropathol Appl Neurobiol 1998; 24: 331-335.
4. Hanna JN, Carney IK, Smith GA, et al. Australian bat lyssavirus infection: a second human case, with a long incubation period. Med J Aust 2000; 172: 597-599.
5. Francis JR, Nourse C, Vaska VL, et al. Australian Bat Lyssavirus in a child: the first reported case. Pediatrics 2014; 133: e1063-e1067. doi: 10. 1542/peds. 2013-1782.
6. Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges. Lancet Neurol 2002; 1: 101-109.
7. Dacheux L, Reynes JM, Buchy P, et al. A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis 2008; 47: 1410-1417.
8. Jackson AC. Current and future approaches to the therapy of human rabies. Antiviral Res 2013; 99: 61-67.
9. Jackson AC, Warrell MJ, Rupprecht CE, et al. Management of rabies in humans. Clin Infect Dis 2003; 36: 60-63.
10. Willoughby RE Jr, Tieves KS, Hoff man GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352: 2508-2514.
11. McCall BJ, Epstein JH, Neill AS, et al. Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999. Emerg Infect Dis 2000; 6: 259-264.
12. Warrilow D, Harrower B, Smith IL, et al. Public health surveillance for Australian bat lyssavirus in Queensland, Australia, 2000-2001. Emerg Infect Dis 2003; 9: 262-264.
13. Grillo T, Cox-Witton K, Post L. Australian Wildlife Health Network. Animal Health Surveillance Quarterly Report 2012; 17: 5-6. http://www. sciquest. org. nz/elibrary/download/81605/Australian_Wildlife_Health_Network. pdf? (accessed Jul 2014).
14. De Serres G, Dallaire F, Côte M, Skowronski DM. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin Infect Dis 2008; 46: 1329-1337.
15. Communicable Diseases Network Australia. Rabies virus and other lyssavirus (including Australian Bat Lyssavirus) exposures and infections: CDNA national guidelines for public health units. http://www. health. gov. au/internet/main/publishing. nsf/Content/cdna-song-abvl-rabies. htm (accessed May 2013).
16. Evans JS, Horton DL, Easton AJ, et al. Rabies virus vaccines: is there a need for a pan-lyssavirus vaccine? Vaccine 2012; 30: 7447-7454.
17. Ewald B, Durrheim D. Australian Bat Lyssavirus: examination of postexposure treatment in NSW. N S W Public Health Bull 2008; 19: 104-107.
18. Young MK, El Saadi D, McCall BJ. Preventing Australian bat lyssavirus: community knowledge and risk perception of bats in South East Queensland. Vector Borne Zoonotic Dis 2014; 14: 284-290.
19. Young MK, McCall BJ. Trends in potential exposure to Australian bat lyssavirus in South East Queensland, 1996 to 2003. Commun Dis Intell Q Rep 2004; 28: 258-260.
20. Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention-United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008; 57: 1-28.
21. Fekadu M, Endeshaw T, Alemu W, et al. Possible human-to-human transmission of rabies in Ethiopia. Ethiop Med J 1996; 34: 123-127.
22. Mattner F, Bitz F, Goedecke M, et al. Adverse eff ects of rabies pre-and postexposure prophylaxis in 290 health-care-workers exposed to a rabies infected organ donor or transplant recipients. Infection 2007; 35: 219-224.
23. Mattner F, Henke-Gendo C, Martens A, et al. Risk of rabies infection and adverse eff ects of postexposure prophylaxis in healthcare workers and other patient contacts exposed to a rabies virus-infected lung transplant recipient. Infect Control Hosp Epidemiol 2007; 28: 513-518.
24. McColl KA, Chamberlain T, Lunt RA, et al. Susceptibility of domestic dogs and cats to Australian bat lyssavirus (ABLV). Vet Microbiol 2007; 123: 15-25.
25. Queensland Government Department of Agriculture, Fisheries and Forestry. Australian bat lyssavirus overview. 2013. http://www. daff. qld. gov. au/animal-industries/animal-health-and-diseases/a-z-list/australianbat-lyssavirus/australian-bat-lyssavirus (accessed Dec 2013).